Tăbăcaru Bogdana, Stanca Horia Tudor, Pîrvulescu Ruxandra Angela, Stanca Simona, Danielescu Ciprian, Munteanu Mihnea, Roșca Cosmin, Teodoru Adrian Cosmin
Department of Ophthalmology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Pediatrics, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Exp Ther Med. 2021 Mar;21(3):288. doi: 10.3892/etm.2021.9719. Epub 2021 Jan 26.
The present study evaluated the efficacy, the safety and the predictability of the Femtosecond laser-assisted keratomileusis (Femto-LASIK) procedure for hyperopia and hyperopic astigmatism. We retrospectively analyzed the postoperative 12-month evolution of 593 eyes with hyperopia and hyperopic astigmatism that underwent Femto-LASIK treatment. The procedure was predictable and effective. No eye lost 2 lines of corrected distance visual acuity (CDVA), demonstrating a safety profile of the procedure. Nine percent of the eyes gained at least one line of CDVA. The accuracy of the spherical equivalent after 12 months was 74% within ±1.0 diopter (D) of emmetropia. The refractive outcomes were stable during the follow-up period. There were no significant complications during the procedure. Femto-LASIK using the VisuMax-MEL 80 platform was demonstrated to be a suitable option to correct selected cases of hyperopia and hyperopic astigmatism. A longer follow-up period is required to better assess the refractive results and to detect any further regression.
本研究评估了飞秒激光辅助准分子原位角膜磨镶术(飞秒LASIK)治疗远视和远视散光的疗效、安全性及可预测性。我们回顾性分析了593只接受飞秒LASIK治疗的远视和远视散光眼术后12个月的情况。该手术具有可预测性且有效。没有眼睛的矫正远视力(CDVA)下降2行,表明该手术具有安全性。9%的眼睛CDVA至少提高了1行。术后12个月等效球镜度在正视眼±1.0屈光度(D)范围内的准确性为74%。随访期间屈光结果稳定。手术过程中无明显并发症。使用VisuMax-MEL 80平台的飞秒LASIK被证明是矫正部分远视和远视散光病例的合适选择。需要更长的随访期来更好地评估屈光结果并检测任何进一步的回退情况。